Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Belgian Research Reveals Extent Of EU’s Digital Health Tech Reimbursement Labyrinth

National reimbursement schemes for digital tech are not just varied but inconsistent in Europe

Executive Summary

Digital medical products pose challenges beyond the scope of existing evaluation frameworks for medical devices, triggering proactive responses at both a national and EU-level. A report by Belgian researchers shows just how complex the situation is.

You may also be interested in...



Future Proofing HTA: How Systems Must Adapt To AI And Digital Medtech

Artificial intelligence is a major advancement in medtech due to its ability to rapidly adapt, improve and learn. However, value assessment models must also reform to keep up with this technology in the medtech space, an HTA expert told Medtech Insight.

Germany’s Digital Health Fast-Track Scheme: What Manufacturers Need To Know

Understanding the German reimbursement system is crucial for any medtech firm eyeing the European market, and healthtech innovators in particular may benefit from its fast-track digital health app scheme. But how does the scheme work, and who can apply?

EU HTA Regulation: Taskforce To Develop Evaluation Framework For Digital Medtech

Several national health technology assessment bodies in Europe have joined forces with EU-level organizations to develop recommendations on harmonized evaluation guidelines for digital medical devices under the upcoming EU Regulation on HTA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel